+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

B

Actively Recruiting

Researchers are evaluating nurse-led treatment for rifampicin-resistant tuberculosis RR-TB in primary care clinics compared to standard physician-led treatment at district hospitals in South Africa. This multi-site, cluster randomized trial aims to assess treatment outcomes, safety, and patient costs over five years. The study also explores how this approach affects HIV co-infected patients and addresses the high costs and access barriers associated with hospital-based care. Participants will receive RR-TB treatment either through nurses available once or twice weekly at primary care clinics or through physicians at hospital outpatient sites. Nurse availability will rotate between clinics to mirror physician duties. The trial will compare the two approaches for treatment success, safety events, and catastrophic costs exceeding 20% of household income. Secondary goals include evaluating timing for treatment initiation, symptom resolution, provider adherence, and cost-effectiveness. During the study, participants will be closely monitored through laboratory tests, clinical assessments, and cost tracking over 12 months. Key outcomes include treatment success at six months, severe adverse events within a year, and patient cost burdens. The study involves regular evaluations of dosing adjustments and HIV-related treatment milestones. Participation spans from initial diagnosis through a year of follow-up, with blinded analysis and safety reviews to ensure data integrity.

Age: 18Years +All GendersPhase Not Applicable
5 locations